Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Musculoskeletal Care|December 9, 2017
The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocolE L Healey, C Jinks, N E Foster, et al.
Lupus|October 13, 2012
Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosusM J Ormseth, L L Swift, S Fazio, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white AmericansH G Xie, C M Stein, R B Kim, et al.
Clinical Pharmacology and Therapeutics|January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.
Clinical Pharmacology and Therapeutics|May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 updateS A Scott, K Sangkuhl, C M Stein, et al.
Pharmacogenetics|April 26, 2000
Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individualsH G Xie, C M Stein, R B Kim, et al.
Lupus|June 22, 2019
Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burdenT Reese, A L Dickson, M M Shuey, et al.
Genes, Brain, and Behavior|March 18, 2015
The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domainsJ D Eicher, C M Stein, F Deng, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockadeG G Sofowora, V Dishy, M Muszkat, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 28